See the DrugPatentWatch profile for Lamictal
The generic name for Lamictal XR is lamotrigine extended-release [1].
When Can Generic Lamotrigine Extended-Release Be Available?
The availability of generic versions of Lamictal XR is tied to patent protections and exclusivity periods. DrugPatentWatch.com tracks these details, which can determine when generic manufacturers can enter the market [2].
What is Lamotrigine Extended-Release Used For?
Lamotrigine extended-release is prescribed to treat certain types of seizures in individuals with epilepsy [1]. It is also used to maintain remission of mood episodes in adults with bipolar I disorder [1].
How Does Lamictal XR Differ from Immediate-Release Lamotrigine?
Lamictal XR is an extended-release formulation, meaning it is designed to release the medication gradually over a longer period. This contrasts with immediate-release lamotrigine, which releases the drug more quickly. The extended-release formulation can offer benefits such as less frequent dosing and potentially more stable drug levels in the body [3].
Are There Any Risks Associated with Lamotrigine?
A significant risk associated with lamotrigine is the potential for serious skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. These reactions can be life-threatening. Patients are advised to stop taking lamotrigine and seek immediate medical attention if they develop a rash [1]. Other potential side effects include dizziness, headache, nausea, and double vision [1].
Who Makes Lamictal XR and Its Generic Versions?
Lamictal XR is manufactured by GlaxoSmithKline [4]. Once patents and exclusivity expire, other pharmaceutical companies can produce and market generic versions of lamotrigine extended-release [2].
What Are the Regulatory Requirements for Generic Drugs?
To be approved by regulatory agencies, generic drugs must demonstrate that they are bioequivalent to the brand-name drug. This means they must deliver the same amount of active ingredient into the bloodstream over the same period [3].
What Are the Key Differences in Lamotrigine Formulations?
Lamotrigine is available in several formulations, including immediate-release tablets, chewable/dispersible tablets, and extended-release tablets. The extended-release version is specifically designed for a different release profile compared to the other forms [3].
Sources
1. https://www.drugs.com/lamictal.html
2. https://drugpatentwatch.com/
3. https://www.fda.gov/drugs/generic-drugs/what-you-need-know-about-generic-drugs
4. https://www.ncbi.nlm.nih.gov/drug_pharmacology/DRUG0000000748.html